FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy

FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy

The described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to...

Full description

Bibliographic Details
Main Authors:	I S Nemchenko, A G Turkina, E Yu Chelysheva, G M Galstyan, A M Kovrigina, N K Khuazheva, V G Savchenko
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2015-12-01
Series:	Терапевтический архив
Subjects:	hypereosinophilic syndrome clonal myeloproliferative disease with eosinophilia imatinib dasatinib
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31887

Similar Items

A rare case of hypereosinophilic syndrome presenting with unilateral proptosis and torticollis
by: Jayanta K Das, et al.
Published: (2018-01-01)

Eosinophilia-myalgia syndrome induced by excessive L-tryptophan intake from cashew nuts
by: Barešić Marko, et al.
Published: (2014-12-01)

Korean Adolescent Patient with Manifestations of Lymphocyte Variant Hypereosinophilic Syndrome and Episodic Angioedema with Eosinophilia, Treated with Reslizumab
by: Jie Hee Jue, et al.
Published: (2022-04-01)

An intriguing case of a paravertebral extramedullary erythropoiesis presenting as tumor‐mimicking lesion in a patient with eosinophilia with FIP1L1‐PDGFRA rearrangement
by: Sassi Farah, et al.
Published: (2022-12-01)

Eosinophilic Myocarditis in Hypereosinophilic Syndrome
by: Rui Assis, et al.
Published: (2020-01-01)

Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder
by: Eli M. Soyfer, et al.
Published: (2023-06-01)

Idiopathic Hypereosinophilic Syndrome with Multiple Organ Involvement
by: Reham Abo Shdid, et al.
Published: (2021-03-01)

Pruritus as a Presenting Symptom of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia
by: Abu-Tineh M, et al.
Published: (2021-12-01)

Salvage therapy of imatinib-resistant hypereosinophilic syndrome with PDGFRB rearrangement
by: Miao-Erh Chang, et al.
Published: (2016-03-01)

A Case of Hypereosinophilic Syndrome Presenting with Multiorgan Thromboses Associated with Intestinal Obstruction
by: Tao Sui, et al.
Published: (2013-09-01)

Eosinophilic cystitis refractory to steroids successfully treated with benralizumab: A case report
by: George N. Konstantinou, et al.
Published: (2023-01-01)

Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes
by: Yuri Albuquerque Pessoa Santos, et al.
Published: (2017-01-01)

Eosinophilic Myocarditis: Clinical Case and Literature Review
by: Paulo Dinis, et al.

Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report
by: Yujie Chen, et al.
Published: (2021-05-01)

Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms
by: Ruth Stuckey, et al.
Published: (2023-08-01)

Extending the duration of response in chronic myelogenous leukemia: targeted therapy with sequential tyrosine kinase inhibitors
by: Michael G. Martin, et al.
Published: (2011-12-01)

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
by: Matthew J. Reilley, et al.
Published: (2017-04-01)

The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome
by: Elena Masselli, et al.
Published: (2021-09-01)

Establishment of the Myeloid TBX-Code Reveals Aberrant Expression of T-Box Gene TBX1 in Chronic Myeloid Leukemia
by: Stefan Nagel, et al.
Published: (2023-12-01)

French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes
by: Matthieu Groh, et al.
Published: (2023-04-01)

Eosinofilia pulmonar Pulmonary eosinophilia
by: Luiz Eduardo Mendes Campos, et al.
Published: (2009-06-01)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
by: Shinya Rai, et al.
Published: (2019-01-01)

Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review
by: M. A. Gurianova, et al.
Published: (2020-09-01)

Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
by: Zhiyu Zhang, et al.
Published: (2023-06-01)

Loeffler endocarditis with intracardiac thrombus: case report and literature review
by: Qian Zhang, et al.
Published: (2021-12-01)

Eosinophilic annular erythema: A striking clinical presentation with potential systemic implications
by: Taylor Gray, DO, et al.
Published: (2021-10-01)

FIP1L1–PDGFRα-Positive Loeffler Endocarditis—A Distinct Cause of Heart Failure in a Young Male: The Role of Multimodal Diagnostic Tools
by: Andreea Varga, et al.
Published: (2023-05-01)

Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
by: Jonas Weiße, et al.
Published: (2021-06-01)

A Challenging Case of Gamma Delta T-Cell Lymphoma with Precursor T-Cells and Marked Eosinophilia: A Case Report
by: Samah Kohla, et al.
Published: (2020-12-01)

Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia
by: Luma Al-Ali, et al.
Published: (2024-02-01)

Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
by: Sarah Allegra, et al.
Published: (2023-09-01)

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia
by: Kota Yoshifuji, et al.
Published: (2022-10-01)

Economic evaluation of dasatinib in the treatment of chronic myeloid leukemia patients resistant to imatinib in Chile
by: Milva Caputo, et al.
Published: (2011-04-01)

Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy
by: A G Turkina, et al.
Published: (2017-12-01)

Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma
by: Reem Akiely, et al.
Published: (2022-12-01)

Angiolymphoid hyperplasia with eosinophilia – A report of three cases
by: Mrinal Gupta
Published: (2018-04-01)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
by: Lasse Kjær
Published: (2020-07-01)

Eosinophilia characterized by a rare CCT6B mutation and responsive to tyrosine kinase inhibition: Case report and literature review
by: Abhay Singh, et al.
Published: (2021-01-01)

Cough in hypereosinophilic syndrome: case report and literature review
by: Jiaxing Xie, et al.
Published: (2020-04-01)